Expanded CVX-300 Claims Are Spectranetics CEO’s First Order Of Business
This article was originally published in The Gray Sheet
Executive Summary
Incoming Spectranetics President/CEO John Schulte is pledging to fulfill the company's strategic goal to expand indications for the CVX-300 excimer laser, starting with critical limb (lower leg) ischemia